BlueNalu Expands Partnership with Nomad Foods
30th April 2025
Agronomics Limited
("Agronomics" or the "Company")
BlueNalu Expands Partnership with Nomad Foods
Agronomics (LSE: ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, BlueNalu, Inc ("BlueNalu"), a global leader in cell-cultivated seafood, has expanded its strategic partnership with Nomad Foods Limited ("Nomad Foods"), Europe's leading frozen food company, to support the commercialisation of its cell-cultivated seafood products in the UK and across Europe.
Nomad Foods and BlueNalu first announced their partnership in 2021. To date, the partnership has explored opportunities to bring cell-cultivated seafood to select markets in the UK and Europe. The new partnership will now see the two companies work together on delivering a market-entry strategy for the sale of BlueNalu's cell-cultivated seafood in the UK, beginning with premium foodservice and limited-time offerings that align with consumer demand for high-quality seafood options.
The partnership will also support BlueNalu's ongoing work with the UK Government. In March, the Government announced that BlueNalu had joined the UK Food Standards Agency's ("FSA") pioneering regulatory programme to help speed up the approval process for cultivated-grown foods. The program enables BlueNalu to work collaboratively with the FSA to navigate the regulatory process for novel foods and ensure the highest food safety and transparency standards. BlueNalu is the only company within the program focused primarily on cell-cultivated seafood.
New research sponsored by BlueNalu also reveals strong enthusiasm among UK sushi consumers for cell-cultivated bluefin tuna toro, which will be its first commercial product. In a survey of 2,000 frequent sushi eaters conducted in 2024, 92% of respondents expressed interest in trying the product. The top perceived benefits included its potential absence of parasites, pesticides, microplastics, mercury, and antibiotics, followed by high omega-3 content. Additionally, 74% expressed willingness to pay the same or more compared to conventional bluefin tuna, due to its potential benefits.
Lou Cooperhouse, Founder, President, and CEO of BlueNalu commented "Our cell-cultivated bluefin toro offers a new, high-quality seafood experience-nutrient-rich, free from environmental contaminants, and designed to complement a global supply chain that is increasingly fragile and unpredictable. We are proud to work with trusted partners and forward-thinking regulatory agencies to deliver safe, consistent, and desirable seafood to consumers in the coming years. Our acceptance into the UK regulatory sandbox reinforces BlueNalu's position as a global company at the forefront of food system innovation."
Jim Mellon, Executive Chair of Agronomics said: "Today's news further exemplifies the ongoing momentum in the cultivated food sector across the globe. This research also confirms what we have known for some time, that there is a strong demand from consumers, who want food options which are not only more sustainable, but ones which are healthier and better for themselves and the planet. We are looking forward to BlueNalu making waves in the UK, as its partnership with Nomad Foods will drive forward innovation in the clean food industry."
To date, Agronomics has invested a total of US$ 8.0 million (c.£6.1 million) in BlueNalu which, subject to audit, is currently carried at £13.0 million. This position represents c.8.6% of Agronomics' last stated Net Asset Value as at 31 December 2024.
For more information about BlueNalu, please visit www.bluenalu.com.
About BlueNalu
BlueNalu is pioneering the future of seafood by developing premium-quality, cell-cultivated seafood products directly from fish cells. Founded in 2018 and headquartered in San Diego, California, the company combines innovative biotechnology with culinary expertise to deliver seafood products that align with consumer preferences for health, safety, and sustainability. BlueNalu is dedicated to supporting a more resilient global seafood supply chain and reducing pressure on wild fish populations.
About Agronomics
Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals.
These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.
|
Agronomics Limited |
Beaumont Cornish Limited |
Canaccord Genuity Limited |
Cavendish Capital Markets Limited |
Peterhouse Capital Limited |
33Seconds Limited |
|
The Company |
Nomad |
Joint Broker |
Joint Broker |
Joint Broker |
Public Relations |
|
Jim Mellon Denham Eke |
Roland Cornish James Biddle |
Andrew Potts Harry Pardoe |
Giles Balleny Michael Johnson |
Lucy Williams Charles Goodfellow |
Jack Ferris Calum Warren-Piper |
|
+44 (0) 1624 639396 info@agronomics.im |
+44 (0) 207 628 3396 |
+44 (0) 207 523 8000 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |
agronomics@33seconds.co |
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago Johnson Matthey
- 5 hours ago Galliford Try
- 5 hours ago Galliford Try
- 5 hours ago Centrica
- 5 hours ago Smith & Nephew